Full View

Drugs improving insulin resistance for non‐alcoholic fatty liver disease and/or non‐alcoholic steatohepatitis

N Goossens, G Isgro, F Negro - The Cochrane Database of …, 2021 - ncbi.nlm.nih.gov
The authors rewrote the background section of the protocol prepared earlier by Angelico
2006, expanded types of studies, and expanded and changed the inclusion criteria. The …
相关文章

[引用][C] Drugs improving insulin resistance for non‐alcoholic fatty liver disease and/or non‐alcoholic steatohepatitis

N Goossens, G Isgro, F Negro… - Cochrane Database …, 1996 - cochranelibrary.com
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To
assess the beneficial and harmful effects of drugs improving insulin resistance for non …

Drugs improving insulin resistance for non‐alcoholic fatty liver disease and/or non‐alcoholic steatohepatitis

N Goossens, G Isgro, F Negro - The Cochrane Database of …, 2021 - europepmc.org
25 March 2013 New citation required and major changes The authors rewrote the
background section of the protocol prepared earlier by Angelico 2006, expanded types of …

[引用][C] Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis

N Goossens, G Isgro, F Negro - Cochrane Database of Systematic …, 2013 - folia.unifr.ch
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic
steatohepatitis SONAR logo Log in Sign up EN English Français Deutsch Italiano Back Drugs …

[引用][C] Drugs improving insulin resistance for non‐alcoholic fatty liver disease and/or non‐alcoholic steatohepatitis

N Goossens, G Isgro, F Negro - Cochrane Database of …, 2021 - cochranelibrary.com
The authors rewrote the background section of the protocol prepared earlier by Angelico
2006, expanded types of studies, and expanded and changed the inclusion criteria. The …